News | January 20, 2026
Avalon clinches majority investment to expand future of diagnostic intelligence
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
The new investment will fuel expansion of Avalon's Diagnostic Intelligence capabilities
The expanded agreement significantly widens the scope of integrated services across the entire drug development lifecycle
The company recorded revenue of Rs. 1,065 crore in the third quarter of FY26
The initiative is being led through the Bank’s CSR programme, Parivartan, in partnership with the Indian Cancer Society
The randomized, double-blind, placebo-controlled Phase 2b VITAL trial enrolled 91 patients with newly diagnosed Stage IIIb–IV epithelial ovarian cancer
The launch of PatroLab is a pivotal milestone, marking a paradigm shift in biologics development and manufacturing
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with mCSCC or laCSCC who are not candidates for curative surgery or curative radiation
The updated closure system introduces intuitive handling, innovative functionality and a premium design compatible with a wide range of syringe formats
The deal to acquire AT-01 (124-Iodine-evuzamitide) and AT-05 (PAR-Peptide + technetium-99m) underscores Bayer’s commitment to expanding in molecular imaging and advancing precision cardiology
The feature will be available across all Max Healthcare facilities, offering patients consistent and convenient access to services nationwide
Subscribe To Our Newsletter & Stay Updated
